A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Davita Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 5,944 shares of DVA stock, worth $976,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,944
Previous 3,782 57.17%
Holding current value
$976,123
Previous $522,000 57.85%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$126.11 - $147.14 $272,649 - $318,116
2,162 Added 57.17%
5,944 $824,000
Q1 2024

Apr 24, 2024

BUY
$103.89 - $139.21 $145,030 - $194,337
1,396 Added 58.51%
3,782 $522,000
Q4 2023

Feb 09, 2024

BUY
$73.2 - $108.8 $174,655 - $259,596
2,386 New
2,386 $250,000
Q3 2022

Oct 17, 2022

SELL
$80.24 - $95.27 $4,172 - $4,954
-52 Reduced 1.59%
3,225 $266,000
Q2 2022

Jul 13, 2022

SELL
$76.05 - $123.38 $20,837 - $33,806
-274 Reduced 7.72%
3,277 $262,000
Q1 2022

May 12, 2022

BUY
$108.37 - $120.0 $26,225 - $29,040
242 Added 7.31%
3,551 $401,000
Q4 2021

Feb 03, 2022

BUY
$94.5 - $116.95 $34,398 - $42,569
364 Added 12.36%
3,309 $376,000
Q3 2021

Nov 02, 2021

BUY
$116.26 - $133.78 $11,742 - $13,511
101 Added 3.55%
2,945 $342,000
Q2 2021

Aug 10, 2021

BUY
$105.44 - $127.98 $13,390 - $16,253
127 Added 4.67%
2,844 $342,000
Q1 2021

May 07, 2021

BUY
$99.98 - $123.89 $12,397 - $15,362
124 Added 4.78%
2,717 $292,000
Q4 2020

Feb 04, 2021

SELL
$82.82 - $117.4 $124,229 - $176,100
-1,500 Reduced 36.65%
2,593 $304,000
Q3 2020

Oct 29, 2020

BUY
$79.57 - $91.84 $1,193 - $1,377
15 Added 0.37%
4,093 $350,000
Q2 2020

Jul 27, 2020

SELL
$65.52 - $88.28 $51,891 - $69,917
-792 Reduced 16.26%
4,078 $322,000
Q1 2020

May 08, 2020

SELL
$64.99 - $88.5 $224,540 - $305,767
-3,455 Reduced 41.5%
4,870 $370,000
Q4 2019

Feb 04, 2020

SELL
$54.2 - $75.03 $89,050 - $123,274
-1,643 Reduced 16.48%
8,325 $624,000
Q3 2019

Nov 06, 2019

BUY
$52.55 - $63.28 $224,651 - $270,522
4,275 Added 75.09%
9,968 $568,000
Q2 2019

Aug 15, 2019

SELL
$43.42 - $57.79 $13,460 - $17,914
-310 Reduced 5.16%
5,693 $0
Q1 2019

May 08, 2019

SELL
$49.95 - $59.21 $9,440 - $11,190
-189 Reduced 3.05%
6,003 $0
Q4 2018

Feb 05, 2019

SELL
$48.73 - $76.08 $9,063 - $14,150
-186 Reduced 2.92%
6,192 $318,000
Q3 2018

Nov 02, 2018

SELL
$66.51 - $74.55 $33,388 - $37,424
-502 Reduced 7.3%
6,378 $0
Q2 2018

Aug 10, 2018

SELL
$62.77 - $73.47 $95,033 - $111,233
-1,514 Reduced 18.04%
6,880 $0
Q1 2018

May 09, 2018

SELL
$65.0 - $80.03 $73,320 - $90,273
-1,128 Reduced 11.85%
8,394 $0
Q4 2017

Feb 22, 2018

SELL
$53.89 - $72.36 $154,448 - $207,383
-2,866 Reduced 23.14%
9,522 $0
Q3 2017

Nov 07, 2017

SELL
$56.13 - $64.78 $328,192 - $378,768
-5,847 Reduced 32.06%
12,388 $736,000
Q2 2017

Aug 08, 2017

BUY
N/A
18,235
18,235 $1.18 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $15B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.